| Literature DB >> 33140490 |
Vadim Kotov1,2,3, Georg Mlynek4, Oliver Vesper1,2,3, Marina Pletzer4, Jiri Wald1,2,3, Celso M Teixeira-Duarte5, Herve Celia6, Maria Garcia-Alai1,7, Stephan Nussberger8, Susan K Buchanan6, João H Morais-Cabral5, Christian Loew1,7, Kristina Djinovic-Carugo4,9, Thomas C Marlovits1,2,3.
Abstract
Protein stability is a key factor in successful structural and biochemical research. However, the approaches for systematic comparison of protein stability are limited by sample consumption or compatibility with sample buffer components. Here we describe how miniaturized measurement of intrinsic tryptophan fluorescence (NanoDSF assay) in combination with a simplified description of protein unfolding can be used to interrogate the stability of a protein sample. We demonstrate that improved protein stability measures, such as apparent Gibbs free energy of unfolding, rather than melting temperature Tm , should be used to rank the results of thermostability screens. The assay is compatible with protein samples of any composition, including protein complexes and membrane proteins. Our data analysis software, MoltenProt, provides an easy and robust way to perform characterization of multiple samples. Potential applications of MoltenProt and NanoDSF include buffer and construct optimization for X-ray crystallography and cryo-electron microscopy, screening for small-molecule binding partners and comparison of effects of point mutations.Entities:
Keywords: MoltenProt; NanoDSF; buffer optimization; high-throughput screening; melting temperature; protein unfolding; thermostability
Year: 2020 PMID: 33140490 PMCID: PMC7737771 DOI: 10.1002/pro.3986
Source DB: PubMed Journal: Protein Sci ISSN: 0961-8368 Impact factor: 6.725
FIGURE 1MoltenProt is a fast and efficient tool for analysis of protein unfolding data. (a) A typical thermal unfolding assay. Signal increases as a protein unfolds with increasing temperature (T). The inflection point of the curve (melting temperature Tm) indicates the temperature where 50% of protein molecules are in an unfolded state. Dashed lines indicate linearly extrapolated baselines, that is, temperature dependence of native or unfolded state fluorescence. Vertical dashed lines denote the transition region (1%–99% of protein molecules are unfolded). (b) Interpretation of slope values for thermal unfolding curves. Curves 1 and 2 have identical Tm, but curve 1 has a steeper (higher) slope. A steeper slope translates to a later onset of unfolding, that is, the temperature at which an arbitrary fraction of protein molecules becomes unfolded. Thus, the folded state of the protein in condition 1 is more resistant to heat, and it could be considered more stabilizing than condition 2. Importantly, these conditions are identical in terms of Tm. (c) A screenshot of the MoltenProt GUI. Left‐hand side presents the samples in a 96‐well format color‐coded for a chosen fit parameter (e.g., ΔGu°′, Tmor ΔHm). Right‐hand side displays one or more curves for comparison and assessment of fit quality. (d) Diversity of tested protein samples (n = 40) by type, oligomeric state, origin and the number of unfolding transitions. State indicates whether a protein sample forms oligomers (homooligomers or heterooligomers) or is a monomeric protein. Mixed origin indicates protein complexes with subcomponents from different species (e.g., antigen–antibody complex)
FIGURE 2ΔGu°′ is a superior thermostability metric compared to Tm. (a) Representative thermal unfolding curves of ExbBD complex at pH 5.5 (blue) or pH 6.9 (gray). Raw fluorescence readings are provided in Figure S2e. (b) Crystal structure of ExbBD at pH 4.5 (blue) and pH 7.0 (gray). The transmembrane domain of ExbD (orange) is only visible in crystals formed at pH 4.5, which have higher thermostability. Two ExbB subunits were removed from display to visualize the lumen of the channel. (c) Representative thermal unfolding curves of KtrAB complex in presence of ATP (blue) or AMP (gray). Raw fluorescence readings are provided in Figure S2f. (d) Crystal structure of KtrAB in complex with ATP (PDB 4J7C). Two KtrB subunits are buried in the membrane and perform cation transport; nucleotide‐bound KtrA forms a tetramer of dimers. The approximate position of the lipid bilayer is shown with dashed lines. One KtrB subunit is shown in green and one KtrA subunit is shown in yellow. (e) Representative thermal unfolding curves of DgoT in presence of DDM (blue) or CHAPS (gray). Raw fluorescence readings are provided in Figure S2g. f) Crystals of the transporter DgoT in purified in 0.03% DDM and crystallized in 0.03 M MgCl2, 0.1 M MES pH 6.5, 28% polyethyleneglycol‐400 (PEG‐400). Scale bar 200 μm. In thermal unfolding curves the intersection with the horizontal dashed line at 0.5 fraction unfolded corresponds to Tm. ΔTm and ΔΔGu are computed by subtraction of the value for a less stable state (gray unfolding curve) from the value of a more stable state (blue unfolding curve). Specific values as well as information on the replicates are provided in Table S5
FIGURE 3Functional insights obtained by ΔGu°′ analysis. (a) Representative thermal unfolding curves of RuvB in presence or absence of ATPgS (blue and gray). Raw fluorescence readings are provided in Figure S3a. (b) RuvB in presence or absence of ATPgS visualized with negative staining electron microscopy (representative images, scale bar 50 nm). Full‐size micrographs are provided in Figure S3b. (c) Representative thermal unfolding curves of α‐actinin‐2 rod domain (gray) and its complex with the intrinsically disordered protein Δ91‐FATZ‐1 (blue). Raw fluorescence readings are provided in Figure S3c. (d) Crystal structure of α‐actinin‐2 dimer (PDB 4D1E) and a schematic representation of FATZ‐1. Rod domain (residues 274–746) of one α‐actinin‐2 subunits is shown in green. Δ91‐FATZ‐1 construct contains a deletion of 91 N‐terminal residues. NTR, N‐terminal region; CTR, C‐terminal region; GRR, glycine‐rich region. (e) Representative thermal unfolding curves of wild type FlnC‐d19 (blue) and cardiomyopathy causing mutation Q2058R (gray). Raw fluorescence readings are provided in Figure S3e. (f) Schematic diagram of FlnC and a model of FlnC‐19 bearing a cardiomyopathy‐causing mutation Q2058R (inset, residues 2036 to 2,130; Q2058R is highlighted in red). The model is based on a partially refined crystal structure of FlnC domains 18 and 19 (Mlynek et al., manuscript in preparation). In thermal unfolding curves (a, c, e) the intersection with the horizontal dashed line at 0.5 fraction unfolded corresponds to Tm. ΔTmand ΔΔGuare computed by subtraction of the value for a less stable state (gray unfolding curve) from the value of a more stable state (blue unfolding curve). Specific values as well as information on the replicates are provided in Table S5
FIGURE 4Exemplary ΔGu°′ heatmaps. (a) Stability of the TOM core complex as a function of pH and buffer system. Each square in the heatmap represents an experimental measurement of ΔGu°′ (n = 2). The middle point of each square is positioned on either categorical axis (buffer system) or numeric axis (pH). Indicated buffer system was added to a final concentration of 100 mM to the original buffer system (20 mM HEPES, pH 7.2). (b) Structure of the TOM core complex. Two copies of Tom40 model (PDB 5O8O, green and gray) were placed in the 6.8 Å electron density map (EMDB 3761). The approximate position of the lipid bilayer is shown with dashed lines. (c) Stability of MdfA as a function of detergent chemistry. Each square in a heatmap represents an experimental measurement of ΔGu°′ (n = 2). The middle point of each square is positioned on either categorical axis (detergent family) or numeric axis (alkyl chain length). Lower heatmap shows the heatmap for alkyl ether detergents (CxEy), where the length of alkyl chain (Cx) is on X‐axis and the length of the hydrophilic PEG component (Ey) is on Y‐axis. FC, fos‐choline; DAO, dimethylamineoxide; Mal, maltoside; Thiomal, thiomaltoside; Glc, glucoside; NG, maltose neopentyl‐glycol. (d) Crystal structure of MdfA in complex with chloramphenicol (PDB 4ZOW). The protein contains two pseudo‐symmetric domains (green and gray) and the amphipatic interdomain linker (yellow). Bound chloramphenicol is shown in orange; the approximate position of the lipid bilayer is shown with dashed lines